MorphoSys Aktie
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Agennix AG | 0 | 0 | 0 | - | - |
| Amgen Inc. | 0 | 0 | 0 | - | - |
| Bayer | 2 | 7 | 0 | 26,88 EUR | -5,40% |
| BB Biotech AG | 0 | 0 | 0 | - | - |
| Biogen Inc | 0 | 0 | 0 | - | - |
| Biotest AG | 0 | 0 | 0 | - | - |
| Eli Lilly | 1 | 0 | 0 | 994,00 USD | +18,35% |
| EVOTEC SE | 2 | 2 | 0 | 8,42 EUR | +25,11% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| MorphoSys | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 4 | 2 | 98,25 CHF | -6,70% |
| Pfizer Inc. | 3 | 4 | 0 | 29,33 USD | +7,16% |
| QIAGEN N.V. | 4 | 1 | 0 | 50,00 EUR | +25,14% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 8 | 1 | 0 | 109,50 EUR | +27,80% |